(Q84255817)
Statements
Sildenafil improves diabetic vascular activity through suppressing endothelin receptor A, iNOS and NADPH oxidase which is comparable with the endothelin receptor antagonist CPU0213 in STZ-injected rats (English)
Lu Luo
De-Zai Dai
Yu-Si Cheng
Qi Zhang
Wen-Jun Yuan